Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals

M. G. Sanz; A. Loynachan; D. W. Horohov

doi:10.1136/vr.103095

Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals

M. G. Sanz, A. Loynachan, D. W. Horohov

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

Since a vaccine is not available against Rhodococcus equi, R equi-specific hyperimmune plasma (HIP) is commonly used, although its efficacy remains controversial. The objective of this study was to evaluate the ability of a commercially available HIP to prevent clinical rhodococcal pneumonia in neonatal foals after experimental challenge.

Original language	English
Pages (from-to)	261
Number of pages	1
Journal	Veterinary Record
Volume	178
Issue number	11
DOIs	https://doi.org/10.1136/vr.103095
State	Published - Mar 12 2016

ASJC Scopus subject areas

Veterinary (all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/vr.103095

Cite this

@article{ff045cbe6459491ea59bcc865c531361,

title = "Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals",

abstract = "Since a vaccine is not available against Rhodococcus equi, R equi-specific hyperimmune plasma (HIP) is commonly used, although its efficacy remains controversial. The objective of this study was to evaluate the ability of a commercially available HIP to prevent clinical rhodococcal pneumonia in neonatal foals after experimental challenge.",

author = "Sanz, {M. G.} and A. Loynachan and Horohov, {D. W.}",

year = "2016",

month = mar,

day = "12",

doi = "10.1136/vr.103095",

language = "English",

volume = "178",

pages = "261",

number = "11",

}

TY - JOUR

T1 - Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals

AU - Sanz, M. G.

AU - Loynachan, A.

AU - Horohov, D. W.

PY - 2016/3/12

Y1 - 2016/3/12

N2 - Since a vaccine is not available against Rhodococcus equi, R equi-specific hyperimmune plasma (HIP) is commonly used, although its efficacy remains controversial. The objective of this study was to evaluate the ability of a commercially available HIP to prevent clinical rhodococcal pneumonia in neonatal foals after experimental challenge.

AB - Since a vaccine is not available against Rhodococcus equi, R equi-specific hyperimmune plasma (HIP) is commonly used, although its efficacy remains controversial. The objective of this study was to evaluate the ability of a commercially available HIP to prevent clinical rhodococcal pneumonia in neonatal foals after experimental challenge.

UR - http://www.scopus.com/inward/record.url?scp=84960436861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960436861&partnerID=8YFLogxK

U2 - 10.1136/vr.103095

DO - 10.1136/vr.103095

M3 - Article

C2 - 26932206

AN - SCOPUS:84960436861

SN - 0042-4900

VL - 178

SP - 261

JO - Veterinary Record

JF - Veterinary Record

IS - 11

ER -

Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this